Holen Sie sich die Stockscreener-App
12.29
4.86%
0.57
Schlusskurs vom Vortag:
$11.72
Offen:
$11.72
24-Stunden-Volumen:
149.55K
Relative Volume:
2.54
Marktkapitalisierung:
$73.27M
Einnahmen:
$100.44M
Nettoeinkommen (Verlust:
$-133.16M
KGV:
-0.4771
EPS:
-25.76
Netto-Cashflow:
$-94.85M
1W Leistung:
+12.19%
1M Leistung:
+32.58%
6M Leistung:
+43.07%
1J Leistung:
+79.94%
1-Tages-Spanne:
$11.52
$12.49
1-Wochen-Bereich:
$10.32
$12.49
52-Wochen-Spanne:
$5.005
$18.70
Atara Biotherapeutics Inc Stock (ATRA) Company Profile
Firmenname
Atara Biotherapeutics Inc
Sektor
Branche
Telefon
805-623-4211
Adresse
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
Vergleichen Sie ATRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRA
Atara Biotherapeutics Inc
|
12.29 | 82.31M | 100.44M | -133.16M | -94.85M | -25.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Atara Biotherapeutics Inc Stock (ATRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-11-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-09 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-07-20 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-07-13 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-13 | Herabstufung | Stifel | Buy → Hold |
| 2022-05-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-05-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-10 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Eingeleitet | Evercore ISI | Outperform |
| 2020-06-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-09-27 | Herabstufung | Goldman | Neutral → Sell |
| 2019-09-16 | Herabstufung | Jefferies | Buy → Hold |
| 2019-06-04 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-05-30 | Eingeleitet | ROTH Capital | Buy |
| 2019-05-23 | Eingeleitet | Stifel | Buy |
| 2019-01-23 | Eingeleitet | Mizuho | Buy |
| 2018-04-10 | Eingeleitet | JP Morgan | Overweight |
| 2018-03-16 | Eingeleitet | Guggenheim | Neutral |
| 2018-03-05 | Bestätigt | Jefferies | Buy |
| 2018-02-28 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-02-15 | Herabstufung | Citigroup | Neutral → Sell |
| 2018-01-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-10-06 | Fortgesetzt | Goldman | Neutral |
Alle ansehen
Atara Biotherapeutics Inc Aktie (ATRA) Neueste Nachrichten
What’s next for Atara Biotherapeutics Inc. stock priceJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - Newser
Understanding Atara Biotherapeutics Inc.’s price movementChart Signals & AI Enhanced Trading Signals - Newser
Measuring Atara Biotherapeutics Inc.’s beta against major indicesJuly 2025 Drop Watch & Accurate Intraday Trading Signals - Newser
Atara Biotherapeutics Inc. Rebound Backed by Sentiment ShiftPortfolio Performance Summary & Short-Term High Return Strategies - newsyoung.net
Risk vs reward if holding onto Atara Biotherapeutics Inc.2025 Trading Volume Trends & Weekly High Return Stock Opportunities - Newser
Elliott Wave Theory Predicts Pullback in Atara Biotherapeutics Inc.Portfolio Gains Report & Low Risk High Reward Trade Ideas - sundaytimes.kr
How high can Atara Biotherapeutics Inc. stock goTrade Risk Assessment & High Win Rate Trade Alerts - Newser
Atara Biotherapeutics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Why Atara Biotherapeutics Inc. is moving todayQuarterly Trade Report & Proven Capital Preservation Methods - Newser
Multi asset correlation models including Atara Biotherapeutics Inc.2025 Market Sentiment & Reliable Price Action Trade Plans - Newser
Atara Biotherapeutics Inc. stock daily chart insightsMarket Volume Report & Low Drawdown Momentum Trade Ideas - Newser
How to interpret RSI for Atara Biotherapeutics Inc. stockQuarterly Investment Review & Safe Entry Momentum Tips - Newser
Drawdown in Atara Biotherapeutics Inc. May Be Nearing EndGold Moves & Daily Momentum Trading Reports - beatles.ru
What does recent volatility data suggest for Atara Biotherapeutics Inc.Trade Entry Summary & Verified Short-Term Plans - Newser
Using Python tools to backtest Atara Biotherapeutics Inc. strategiesJuly 2025 Setups & Consistent Growth Equity Picks - Newser
There's No Escaping Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Muted Revenues Despite A 25% Share Price Rise - simplywall.st
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - 富途牛牛
Will Atara Biotherapeutics Inc. bounce back from current supportIPO Watch & Accurate Technical Buy Alerts - Newser
Risk adjusted return profile for Atara Biotherapeutics Inc. analyzedFree Early Entry Picks Before News Breakout - Newser
What makes Atara Biotherapeutics Inc. stock price move sharplyStrong ROI Equity Ideas - kangso.co.kr
Is Atara Biotherapeutics Inc. building a consolidation baseDaily Investment Ideas with Market Insight - Newser
Atara Biotherapeutics: Q2 Earnings Snapshot - Norwalk Hour
Technical signs of recovery in Atara Biotherapeutics Inc.Trend Confirmation Scanner with Entry Focus - Newser
How Atara Biotherapeutics Inc. stock performs during market volatilityConsistent Gain Plan with AI Support - Newser
Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress - BioSpace
Atara Biotherapeutics shares rise 2.13% after-hours after FDA accepted BLA for tabelecleucel. - AInvest
Atara Biotherapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress | ATRA Stock News - GuruFocus
Atara Biotherapeutics Reports Q2 Financial Results, Resumes Strategic Options Evaluation - AInvest
Will Atara Biotherapeutics Inc. price bounce be sustainableCapital Safe Picks with Consistent Gains - Newser
What MACD signals say about Atara Biotherapeutics Inc.High Return Idea With Technical Filter - Newser
Is Atara Biotherapeutics Inc. showing signs of accumulationBuy Strategy Tracker with Growth Indicators - Newser
Atara Biotherapeutics (ATRA) Projected to Post Quarterly Earnings on Monday - Defense World
Atara ATRA Q2 2025 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
Atara Biotherapeutics Inc expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Biotech with Heart: Atara’s Path to Hope for MS & Cancer - Tomorrow's World Today
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Is About To Turn The Corner - sg.finance.yahoo.com
What is Atara Biotherapeutics Inc. company’s growth strategyUnlock powerful portfolio management tools - Jammu Links News
Is Atara Biotherapeutics Inc. stock ready for a breakoutHigh Return Trade Roadmap with Setup Filters - Newser
What is the risk reward ratio of investing in Atara Biotherapeutics Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News
What are analysts’ price targets for Atara Biotherapeutics Inc. in the next 12 monthsStrong return on investment - Jammu Links News
What are the latest earnings results for Atara Biotherapeutics Inc.Rapid wealth multiplication - Jammu Links News
Does Atara Biotherapeutics Inc. stock perform well during market downturnsHigh-yield trading alerts - Jammu Links News
When is Atara Biotherapeutics Inc. stock expected to show significant growthUnlock powerful portfolio optimization tools - Jammu Links News
What analysts say about Atara Biotherapeutics Inc. stockDiscover stocks with explosive upside potential - Jammu Links News
Should I hold or sell Atara Biotherapeutics Inc. stock in 2025Maximize profits with strategic stock selection - Jammu Links News
What institutional investors are buying Atara Biotherapeutics Inc. stockTriple-digit wealth increases - Jammu Links News
What are Atara Biotherapeutics Inc. company’s key revenue driversGet real-time alerts on top-performing stocks - Jammu Links News
What drives Atara Biotherapeutics Inc. stock priceUnlock daily market insights for better trades - Jammu Links News
What is the dividend policy of Atara Biotherapeutics Inc. stockMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Atara Biotherapeutics Inc. stock higher in 2025Discover high-growth stocks for your portfolio - Jammu Links News
Finanzdaten der Atara Biotherapeutics Inc-Aktie (ATRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):